Watchlist Price Alert

Revance Therapeutics Inc. (RVNC)

NASDAQ: RVNC · Real-Time Price · USD

3.65

0.00 (0.00%)

At close: Feb 05, 2025, 3:59 PM

Revance Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-323.99M	-356.42M	-281.31M	-282.09M	-159.43M	-142.57M	-120.59M	-89.27M
Depreciation & Amortization	13.69M	39.15M	19.85M	10.25M	2.91M	1.73M	1.47M	1.45M
Stock-Based Compensation	47.81M	52.34M	43.43M	36.45M	17.92M	16.27M	13.23M	11.95M
Other Working Capital	-19.53M	20.11M	2.85M	29.29M	34.63M	51.15M	3.84M	1.81M
Other Non-Cash Items	89.79M	70.72M	1.17M	19.63M	810K	175K	176K	2.41M
Deferred Income Tax	n/a	n/a	89K	-2.72M	-2.65M	-2.57M	3.93M	10.88M
Change in Working Capital	-43.88M	665K	-4.77M	39.97M	34.27M	22.72M	6.44M	2.76M
Operating Cash Flow	-216.57M	-193.55M	-221.54M	-178.5M	-106.16M	-104.25M	-95.34M	-59.83M
Capital Expenditures	-6.89M	-23.01M	-18.07M	-4.22M	-3.24M	-7.09M	-2.63M	-3.47M
Cash Acquisitions	n/a	19.8M	7.7M	-818K	8K	100K	100K	1.8M
Purchase of Investments	-263.92M	-347.97M	-183.59M	-259.3M	-331.36M	-314.91M	-36.03M	-280.68M
Sales Maturities Of Investments	385.43M	232.18M	172M	276.47M	317M	213.44M	157.44M	208.65M
Other Investing Acitivies	-4.88M	-19.8M	-7.7M	17.05M	-14.36M	1.44M	-100K	-1.8M
Investing Cash Flow	109.74M	-138.8M	-29.66M	12.13M	-17.59M	-107.03M	118.79M	-75.5M
Debt Repayment	30.16M	87.05M	n/a	287.5M	n/a	-932K	-3.64M	-3.54M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-2.21M	n/a	-507K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	6.22M	-3.37M	8.16M	-39.96M	-1.18M	2.71M	3.35M	899K
Financial Cash Flow	136.57M	331.69M	29.87M	331.48M	221.66M	1.78M	195.94M	-2.64M
Net Cash Flow	29.73M	-652K	-221.33M	165.11M	97.9M	-209.49M	219.39M	-137.97M
Free Cash Flow	-223.46M	-216.56M	-239.61M	-182.72M	-109.4M	-111.34M	-97.97M	-63.3M